Free Trial

Canopy Growth (TSE:WEED) Shares Down 18.2%

→ $1,500 to $9,400 in one month? (A.I. Trade List) (From Prosper Trading Academy) (Ad)

Canopy Growth Corp (TSE:WEED - Get Free Report)'s stock price dropped 18.2% during trading on Wednesday . The stock traded as low as C$15.63 and last traded at C$16.73. Approximately 2,499,465 shares changed hands during trading, a decline of 8% from the average daily volume of 2,725,777 shares. The stock had previously closed at C$20.45.

Analyst Ratings Changes

A number of research firms have weighed in on WEED. Jefferies Financial Group decreased their price target on Canopy Growth from C$7.28 to C$4.90 and set a "hold" rating for the company in a report on Tuesday, February 27th. Sanford C. Bernstein boosted their target price on shares of Canopy Growth from C$1.49 to C$6.70 in a research report on Tuesday, January 30th. Finally, Bank of America lowered their price target on shares of Canopy Growth from C$7.00 to C$4.00 in a report on Wednesday, February 14th.

Check Out Our Latest Report on WEED

Canopy Growth Stock Performance

The company has a debt-to-equity ratio of 127.28, a quick ratio of 2.32 and a current ratio of 1.79. The company has a 50 day moving average price of C$8.57 and a 200 day moving average price of C$5.21. The company has a market capitalization of C$1.44 billion, a PE ratio of -0.71, a PEG ratio of -0.01 and a beta of 1.63.

Canopy Growth Company Profile

(Get Free Report)

Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names.

Read More

→ Shocking $16T Elon Musk Crypto Leak (From Crypto 101 Media) (Ad)

Should you invest $1,000 in Canopy Growth right now?

Before you consider Canopy Growth, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Canopy Growth wasn't on the list.

While Canopy Growth currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Featured Articles and Offers

Search Headlines: